Results of FDA Reform Poll: speed up clinical trials & expand compassionate use

FDA poll stem cellsThe poll I put up asking people their #1 top priority for FDA reform drew relatively big numbers of respondents.

Speeding up clinical trials was clearly way out in front at #1.

Expanding compassionate use was #2.

These were followed by changing policy to no longer define lab-grown stem cells as drugs and FDA being more proactive against non-compliant clinics.

 

Subscribe to Our Newsletter

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.